Cargando…
Serum lactate is associated with increased illness severity in immunocompromised pediatric hematology oncology patients presenting to the emergency department with fever
INTRODUCTION: Determining which febrile pediatric hematology/oncology (PHO) patients will decompensate from severe infection is a significant challenge. Serum lactate is a well-established marker of illness severity in general adult and pediatric populations, however its utility in PHO patients is u...
Autores principales: | Slatnick, Leonora Rose, Miller, Kristen, Scott, Halden F., Loi, Michele, Esbenshade, Adam J., Franklin, Anna, Lee-Sherick, Alisa B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583361/ https://www.ncbi.nlm.nih.gov/pubmed/36276165 http://dx.doi.org/10.3389/fonc.2022.990279 |
Ejemplares similares
-
Hematology and Oncology in Critical Illness
por: Brandão, Leonardo R., et al.
Publicado: (2011) -
Hematologic and oncologic complications in the critically ill child.
por: McIntosh, S.
Publicado: (1984) -
Impact of COVID-19 on Pediatric Immunocompromised Patients
por: Connelly, James A., et al.
Publicado: (2021) -
1074 Immunization Practices of Pediatric Oncology Providers Towards Children with Acute Lymphoblastic Leukemia that have Completed Chemotherapy
por: Sulieman, Salwa, et al.
Publicado: (2014) -
Early risk stratification in patients with oncological and hematological malignancies in the emergency department
por: Rast, A, et al.
Publicado: (2014)